Inthera Bioscience
Inthera Bioscience is focused on developing inhibitors of intracellular protein interactions employing a proprietary technology platform.
Inthera Bioscience is a company in biotechnology, health care, pharmaceutical based in Europe, Middle East, and Africa (EMEA), founded in 2013.
As a business in biotechnology, health care, pharmaceutical, Inthera Bioscience is listed here with the public details available about it.
The company is recorded as being based in Europe, Middle East, and Africa (EMEA).
It is recorded at the Series_A stage.
The company reports a headcount in the c_00011_00050 range.
Total disclosed funding stands at about $20.1M.
| Sector | Biotechnology, Health Care, Pharmaceutical |
|---|---|
| Headquarters | Europe, Middle East, and Africa (EMEA) |
| Founded | 2013 |
| Employees | c_00011_00050 |
| Stage | series_a |
| Total funding | $20,058,358 |
Website: intherabio.com
Contact details and direct channels are available to signed-in members.
Create a free account
Create a free account